Zhen Su, MD, MBA, is the SVP, Head of U.S. and Global Oncology Franchise. In this role, Dr. Su oversees all commercial operations for the franchise in the US and also global commercial efforts for our oncology therapies.

A physician executive with more than 20 years of experience, Dr. Su held roles at a number of academic institutions – including at Duke University and University of Florida, where he led early clinical development in Immuno-Oncology as a faculty member – before joining the biopharmaceutical industry.

Within EMD Serono, he previously held the position of Chief Medical Officer for EMD Serono, working with the medical, development and regulatory teams to lead EMD Serono’s medical strategy, clinical presence and scientific leadership in the US. Before joining EMD Serono, he held leadership roles in general management, clinical development and medical affairs at Sanofi and GlaxoSmithKline.

Dr. Su earned his MD from the Technical University of Dresden, Germany and completed his MBA training at the University of Toronto, Canada.